Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects
Chemistry & Biodiversity · 2026-06 · 23 (6)
DOI: 10.1002/cbdv.71416 ↗At a glance
Journal article in Chemistry & Biodiversity, published online on 2026-06-18. Written by Serhii Sinyavskyi and 7 co-authors. Institution: Institute of Chemistry and Geology, Oles Honchar Dnipro National University, Dnipro, Ukraine. Major MEDLINE topics: Triazines, Antineoplastic Agents, Drug Design, Triazoles. 60 references. Funded by: Ministry of Education and Science of Ukraine, Ministry of Foreign Affairs of the Czech Republic.
Abstract (original language)
A strategy has been developed for identification of biologically active compounds among unknown benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines, based on the application of conformational restriction in the series of ([2‐(3‐R‐1 H ‐[1,2,4]triazol‐5‐yl)phenyl]amines with known chemotherapeutic activity. The target compounds were synthesized by diazotization of the corresponding ([2‐(3‐R‐1 H ‐[1,2,4]triazol‐5‐yl)phenyl]amines followed by cyclization of the formed diazo‐compounds. The structures of products have been proven by IR, LC–MS, NMR spectroscopy, and x‐ray structural analysis. Cytotoxicity screening was performed on a panel of cell lines derived from various tumor types and pseudo‐normal cell lines. It was demonstrated that benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines have selective antiproliferative activity against Jurkat cell lines with IC 50 ranging from 7.64 to >100 µM. We identified 2‐(naphthaline‐1‐ylmethyl)benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazine ( 2e ) with high cytotoxic activity against this cell line with an IC 50 of 7.64 µM. It is noteworthy that the conformational restrictions imposed proved to be a promising strategy for searching for biologically active compounds, and additional structural modification may lead to more effective and promising antitumor agents.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Chemistry and Geology, Oles Honchar Dnipro National University, Dnipro, Ukraine.
- National University «Zaporizhzhia Polytechnic», Zaporizhzhia, Ukraine.
- Zaporizhzhia State Medical and Pharmaceutical University, Zaporizhzhia, Ukraine.
- Institute of Organic Chemistry of the National Academy of Sciences of Ukraine, Kyiv, Ukraine.
- Institute of Cell Biology of the National Academy of Sciences of Ukraine, Lviv, Ukraine.
- Molecular Design Center, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
ORCID profiles: Oleksii Antypenko
Funding
- Ministry of Education and Science of Ukraine
- Ministry of Foreign Affairs of the Czech Republic
Cite
APA
Sinyavskyi, S., Koptieva, S., Voskoboinik, O., Antypenko, O., Bohdan, N., Kozak, Y., Shishkina, S., & Kovalenko, S. (2026). Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects. Chemistry & Biodiversity, 23(6). https://doi.org/10.1002/cbdv.71416
Vancouver
Sinyavskyi S, Koptieva S, Voskoboinik O, Antypenko O, Bohdan N, Kozak Y, et al. Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects. Chemistry & Biodiversity. 2026;23(6). doi:10.1002/cbdv.71416
BibTeX
@article{Sinyavskyi2026,
author = {Sinyavskyi, Serhii and Koptieva, Svitlana and Voskoboinik, Oleksii and Antypenko, Oleksii and Bohdan, Natalia and Kozak, Yuliia and Shishkina, Svetlana and Kovalenko, Serhii},
title = {Benzo[ e ][1,2,4]triazolo[1,5‐ c ][1,2,3]triazines: Design, Synthesis, and Cytotoxic Effects},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {6},
doi = {10.1002/cbdv.71416}
}
EUVIMED